
Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother
2014; Taylor & Francis; Volume: 36; Issue: 10 Linguagem: Inglês
10.1080/07399332.2014.948627
ISSN1096-4665
AutoresYára Dadalti Fragoso, Tarso Adoni, Soniza Vieira Alves‐Leon, N Azambuja, Amilton Antunes Barreira, Joseph Bruno Bidin Brooks, Denise Sisteroli Diniz Carneiro, Margarete J. Carvalho, Rinaldo Claudino, Elizabeth Regina Comini-Frota, Renán Barros Domingues, Alessandro Finkelsztejn, Paulo Diniz da Gama, Maria Cristina B. Giacomo, Sidney Gomes, Marcus Vinícius Magno Gonçalves, Anderson Kuntz Grzesiuk, Damacio Ramón Kaimen-Maciel, María Fernanda Mendes, Nívea Macedo Oliveira Morales, Rogério Rizo Morales, André Muniz, Regina Maria Papais Alvarenga, Mônica Koncke Fiuza Parolin, Steve Biko Menezes Hora Alves Ribeiro, Heloísa Helena Ruocco, Pedro Rippel Salgado, Fábio Siquineli, Doralina Guimarães Brum, Elza Dias Tosta, Cláudia Cristina Ferreira Vasconcelos, Sandra Maria Garcia de Almeida, Daniella Freire Ribeiro Bernardes, Simone Nascimento Castro, Rodrigo Assad Diniz da Gama, Fabrizio Antonio Resende Gomide, Juliana Finkelzstejn, Josiane Lopes, Fabiani Honorato de Barros Lourenco, Gisele Alexandre Lourenço, Celso Luis Silva Oliveira, Francisco Tomaz Meneses de Oliveira, Lucas Felix de Oliveira, Cristiane Borges Patroclo, Wildéa Lice de Carvalho Jennings Pereira, Juliana Safanelli, Alinne Martiniano Sahdo, Patricia Correa de Oliveira Saldanha, Yves Fumio Shinzato, Jorge Murilo Barbosa Souza, Denis Evandro Zani,
Tópico(s)Autoimmune and Inflammatory Disorders Research
ResumoMultiple sclerosis (MS) is a chronic, neurological, immune-mediated disease that can worsen in the postpartum period. There is no consensus on the use of immunoglobulin for prevention of disease relapses after delivery. We have shown that the controversial beneficial effect of immunoglobulin given immediately after birth could not be observed in patients with MS.
Referência(s)